IRIS
CERNARO, Valeria
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 6.206
NA - Nord America 6.098
AS - Asia 3.324
SA - Sud America 982
Continente sconosciuto - Info sul continente non disponibili 276
AF - Africa 106
OC - Oceania 14
Totale 17.006
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.921
RU - Federazione Russa 3.467
SG - Singapore 1.261
CN - Cina 1.010
BR - Brasile 832
IE - Irlanda 707
SE - Svezia 595
IT - Italia 384
HK - Hong Kong 347
DE - Germania 252
VN - Vietnam 198
FR - Francia 184
PL - Polonia 170
GB - Regno Unito 144
IN - India 124
FI - Finlandia 113
BD - Bangladesh 89
CA - Canada 81
AR - Argentina 56
TR - Turchia 51
MX - Messico 46
IQ - Iraq 39
ZA - Sudafrica 34
EC - Ecuador 31
BE - Belgio 25
ES - Italia 25
JP - Giappone 24
PK - Pakistan 24
NL - Olanda 23
CO - Colombia 20
CZ - Repubblica Ceca 20
ID - Indonesia 20
UZ - Uzbekistan 19
UA - Ucraina 18
AT - Austria 17
JM - Giamaica 16
KE - Kenya 16
MA - Marocco 13
VE - Venezuela 13
AE - Emirati Arabi Uniti 12
SA - Arabia Saudita 11
AU - Australia 10
AZ - Azerbaigian 9
EG - Egitto 9
PH - Filippine 9
PY - Paraguay 9
CH - Svizzera 8
KG - Kirghizistan 8
MY - Malesia 8
NP - Nepal 8
AL - Albania 7
CI - Costa d'Avorio 7
CL - Cile 7
IL - Israele 7
PE - Perù 7
TN - Tunisia 7
DO - Repubblica Dominicana 6
HN - Honduras 6
BG - Bulgaria 5
DK - Danimarca 5
DZ - Algeria 5
ET - Etiopia 5
EU - Europa 5
NO - Norvegia 5
PS - Palestinian Territory 5
TT - Trinidad e Tobago 5
GT - Guatemala 4
JO - Giordania 4
LT - Lituania 4
LV - Lettonia 4
NZ - Nuova Zelanda 4
RO - Romania 4
AM - Armenia 3
BH - Bahrain 3
BY - Bielorussia 3
GE - Georgia 3
GR - Grecia 3
KR - Corea 3
LA - Repubblica Popolare Democratica del Laos 3
LB - Libano 3
LK - Sri Lanka 3
MD - Moldavia 3
TW - Taiwan 3
AO - Angola 2
BB - Barbados 2
BN - Brunei Darussalam 2
BO - Bolivia 2
CR - Costa Rica 2
GP - Guadalupe 2
GY - Guiana 2
HU - Ungheria 2
KZ - Kazakistan 2
NG - Nigeria 2
NI - Nicaragua 2
OM - Oman 2
PA - Panama 2
RS - Serbia 2
SN - Senegal 2
SR - Suriname 2
TJ - Tagikistan 2
Totale 16.715
Salva come PNG Salva come JPEG
Città #
Ashburn 1.019
Moscow 951
Dublin 705
Dallas 703
Singapore 689
Chandler 572
San Jose 374
Hong Kong 344
Beijing 332
Nyköping 332
New York 165
The Dalles 161
Warsaw 157
Council Bluffs 152
Los Angeles 149
Munich 113
Dearborn 111
Boardman 109
Princeton 104
Jacksonville 101
Lauterbourg 95
Medford 93
Ann Arbor 90
Messina 80
Des Moines 75
Cambridge 72
São Paulo 68
Ho Chi Minh City 64
Jinan 55
Santa Clara 49
Shenyang 49
Tianjin 49
Houston 48
Bremen 44
Redondo Beach 44
Hanoi 42
Buffalo 41
Frankfurt am Main 41
Hyderabad 40
San Mateo 40
Turku 37
Orem 36
Seattle 30
Brooklyn 29
Pune 29
Montreal 28
Wilmington 28
Lancaster 27
Guangzhou 26
Catania 25
Rio de Janeiro 24
Chicago 23
Brussels 22
Denver 22
Johannesburg 22
Nanjing 22
Mexico City 20
Rome 20
Tokyo 20
Hebei 19
Manchester 19
Phoenix 19
Stockholm 19
Belo Horizonte 18
Curitiba 17
London 17
Poplar 17
Toronto 17
Ankara 16
Haikou 16
Hangzhou 16
San Francisco 16
Atlanta 15
Baghdad 15
Brno 15
Ningbo 15
Tashkent 15
Brasília 14
Chennai 14
Columbus 14
Düsseldorf 13
Kingston 13
Milan 13
Shanghai 13
Amsterdam 12
Jiaxing 12
Lentini 12
Nairobi 12
Palermo 12
Campinas 11
Miami 11
Najaf 11
Nuremberg 11
Taizhou 11
Wroclaw 11
Zhengzhou 11
Calgary 10
Dong Ket 10
Goiânia 10
Guayaquil 10
Totale 9.584
Salva come PNG Salva come JPEG
Nome #
Marked improvement of thyroid function and autoimmunity by Aloe barbadensis miller juice in patients with subclinical hypothyroidism 396
[Long-term outcome of renal function in women with preeclampia and pregestational diabetes] 259
[Periorbital purpura: a pathognomonic but late sign of AL amyloidosis] / Porpora periorbitaria: un segnale patognomonico ma tardivo di amiloidosi AL 245
[Lupus Nephritis and Enteritis, a dual simultaneous involvement with Arteriolar Thrombosis] 235
[Complement factor B mutation in atypical hemolytic uremic syndrome. Rare cause of rare disease] 233
[From hyponatremia to tolvaptan] 230
Metformin-related lactic acidosis: is it a myth or an underestimated reality? 226
Auxine: thermodynamic properties, complexing ability and dosage in human serium 223
ANTI-INFLAMMATORY ACTION OF DENOSUMAB IN VIVO AND IN VITRO 221
[From oxygen to erythropoietin, as a protagonist of the skin-brain-kidney axis]. 216
[Long-term outcome of renal function in women with preeclampia and pregestational diabetes] 212
Mortalità e morbidità dei pazienti dializzati in Sicilia: studio epidemiologico analitico sul confronto tra metodiche convettive e diffusive 208
Sclerostin levels in uremic patients: a link between bone and vascular disease 204
Progress in pharmacotherapy for the treatment of hyperphosphatemia in renal failure 201
Auxin induces cell proliferation in an experimental model of mammalian renal tubular epithelial cells 201
AKI - EXPERIMENTAL MODELS 198
Role of Paricalcitol in Modulating the Immune Response in Patients with Renal Disease 198
Down with the erythropoietin. Long live the erythropoietin! 193
Fibrosis, regeneration and cancer: what is the link? 191
The Myth of Water and Salt: From Aquaretics to Tenapanor 190
Delayed graft function and chronic allograft nephropathy: Diagnostic and prognostic role of neutrophil gelatinase-associated lipocalin 185
Acetate-free biofiltration to remove fibroblast growth factor 23 in hemodialysis patients: a pilot study 182
A new therapy for kidney injury: regeneration. 180
Antioxidant agents for delaying diabetic kidney disease progression: A systematic review and meta-analysis 179
Beneficial effects of oral pure caffeine on oxidative stress 178
Kidney disease and psoriasis: novel evidences beyond old concepts 177
Before and after preeclampsia: What biomarkers are there? 173
Apelin, Plasmatic Osmolality and Hypotension in Dialyzed Patients. 169
Convective Dialysis Reduces Mortality Risk: Results From a Large Observational, Population-Based Analysis 169
Opposite actions of urotensin II and relaxin-2 on cellular expression of fibronectin in renal fibrosis: A preliminary experimental study 168
Erythropoietin and the truths of science. 167
Negative Emotions in End-Stage Renal Disease: Are Anxiety Symptoms Related to Levels of Circulating Catecholamines? 167
Relaxin: New Pathophysiological Aspects and Pharmacological Perspectives for an Old Protein. 166
Emerging therapeutic strategies for minimal change disease and focal and segmental glomerulosclerosis 164
Lipid disorders in patients with renal failure: Role in cardiovascular events and progression of chronic kidney disease 163
Kidney biopsy in type 2 diabetic patients: Critical reflections on present indications and diagnostic alternatives 162
Renoprotective effect of erythropoietin in zebrafish after administration of gentamicin: an immunohistochemical study for β-catenin and c-kit expression 161
Vascular access for hemodialysis: current perspectives 159
Nephro-oncology: a link in evolution 159
L’ERITROPOIETINA HA AZIONE NEFROPROTETTIVA IN UN MODELLO SPERIMENTALE DI ZEBRAFISH (DANIO RERIO) DOPO SOMMINISTRAZIONE DI GENTAMICINA 158
Gender differences in new hypoglycemic drug effects on renal outcomes: a systematic review 158
The relationship between coping, emotion regulation, and quality of life of patients on dialysis 156
Antiproteinuric effect of DPP-IV inhibitors in diabetic and non-diabetic kidney diseases 156
Indole-3-acetic acid correlates with monocyte-to-high-density lipoprotein (HDL) ratio (MHR) in chronic kidney disease patients 156
Semaphorin 3A serum levels are influenced by haemodialysis: what clinical significance? 155
Salt-water imbalance and fluid overload in hemodialysis patients: a pivotal role of corin 154
From water to aquaretics: a legendary route. 154
COMPARISON OF SEVELAMER, SEVELAMER CARBONATE AND LANTHANIUM CARBONATE IN VITRO AND IN VIVO 153
Squilibri idrico-salini e sovraccarico di liquidi nei pazienti dializzati, il ruolo centrale di Corin 152
Correlation between Hyperkalemia and the Duration of Several Hospitalizations in Patients with Chronic Kidney Disease 151
Kidney-lung connections in acute and chronic diseases: current perspectives 150
Erithropoietin exerts a renoprotective action in an experimental model of zebrafish (Danio Rerio) after administration of gentamicin 149
L'AUXINA INDUCE PROLIFERAZIONE CELLULARE IN UN MODELLO SPERIMENTALE DI CELLULE EPITELIALI TUBULARI RENALI 149
An overview of experimental and early investigational therapies for the treatment of polycystic kidney disease 149
Stress-induced hashitoxicosis: Case report and relative HLA serotype and genotype 149
Xanthine oxidase inhibitors for improving renal function in chronic kidney disease patients: An updated systematic review and meta-analysis 149
Monocyte to HDL ratio: a novel marker of resistant hypertension in CKD patients 148
Role of Vitamin D in Vascular Complications and Vascular Access Outcome in Patients with Chronic Kidney Disease 146
Regenerative medicine: does Erythropoietin have a role? 146
CIGARETTE SMOKE AND ENDOTHELIAL DYSFUNCTION: NGAL A NEW BIOMARKER 143
SCLEROSTIN CAN BE A NEW "KEY PLAYER" IN VASCULARCALCIFICATION IN CKD? 142
Maternal and Fetal Outcomes of Pregnancy in Nephrotic Syndrome Due to Primary Glomerulonephritis 142
Autoimmunity and Infection in Glomerular Disease 141
Proteinuric effect of transcranial magnetic stimulation in healthy subjects and diabetic patients with stage 3-4 CKD 141
Cross-sectional evaluation of kidney function in hospitalized patients: estimated GFR versus renal scintigraphy 141
Monoclonal antibodies for renal diseases: current concepts and ongoing treatments 140
New options for the management of polycystic kidney disease 139
Renal function is associated with changes in bone mineral density in postmenopausal osteoporotic women treated with Denosumab: data from a retrospective cohort study 137
Novel avenues for treating diabetic nephropathy: new investigational drugs 135
COMPARISON OF FORMULAS TO ESTIMATE THE GLOMERULAR FILTRATION RATE WITH THAT OF SCINTIGRAPHY EVALUATION OF KIDNEY FUNCTION IN HOSPITALIZED PATIENTS 135
Erythropoiesis and chronic kidney disease–related anemia: From physiology to new therapeutic advancements 135
Renal biopsy: Still a landmark for the nephrologist 134
RAS inhibition modulates kynurenine levels in a CKD population with and without type 2 diabetes mellitus 133
Complement Inhibition Therapy and Dialytic Strategies in Paroxysmal Nocturnal Hemoglobinuria: The Nephrologist's Opinion 133
QUANTITATIVE ULTRASOUND OF BONE AND HANDGRIP STRENGTH ARE RELATED TO FRACTURE RISK IN HEMODIALYSIS PATIENTS 130
Unexpected hypercalcemia in a diabetic patient with kidney disease 129
Role of Vitamin D Status in Diabetic Patients with Renal Disease 129
Higher serum sclerostin levels and insufficiency of vitamin D are strongly associated with vertebral fractures in hemodialysis patients: a case control study 127
NGAL AND ANESTHETICS: PROTECTIVE ROLE OF SEVOFLURANE 126
FP042AUXIN INDUCES CELL PROLIFERATION IN AN EXPERIMENTAL MODEL OF MAMMALIAN RENAL TUBULAR EPITHELIAL CELLS 125
Protective role of vitamin d in renal tubulopathies 120
Modifications in relaxin's serum levels during acetate-free biofiltration (AFB): only a new biomarker? 119
NGAL is a precocious marker of therapeutic response. 117
Does Erythropoietin Always Win? 115
NEW MARKERS OF VASCULAR AND CARDIAC DYSFUNCTION IN PATIENTS WITH CHRONIC KIDNEY DISEASE (CKD) 115
Maternal peripheral blood CD34+ cells for prediction of fetal kidney malformations: results from a case-control analysis 114
Exploring the effects of DPP-4 inhibitors on the kidney from the bench to clinical trials 108
Comparison between creatinine clearance and eGFRcyst-crea: a real-life experience 105
NGAL as an early biomarker of kidney disease in Joubert syndrome: three brothers compared. 104
Commonly used immunosuppressive drugs for kidney diseases and pregnancy: focus on open questions 103
Endothelial progenitor cells at the interface of chronic kidney disease: from biology to therapeutic advancement 103
Differences in Efficacy between Antibacterial Lock Therapy and the Standard of Care for CVC-Related Infections: A Systematic Review and Meta-Analysis 102
New Insights on the Role of Vitamin D in the Progression of Renal Damage 96
Immune Checkpoint Inhibitors and the Kidney: A Focus on Diagnosis and Management for Personalised Medicine 92
Clinical evaluation of the safety, efficacy and tolerability of lanthanum carbonate in the management of hyperphosphatemia in patients with end-stage renal disease 92
Review and Practical Excursus of the Propensity Score: Low Protein Diet Compared to Mediterranean Diet in Patients With Chronic Kidney Disease 92
Hyperphosphatemia in Chronic Kidney Disease: The Search for New Treatment Paradigms and the Role of Tenapanor 90
UROTENSIN AND RELAXIN: OPPOSITE ACTIONS AND POTENTIAL THERAPEUTIC APPLICATIONS IN RENAL FIBROSIS 90
The future of phosphate binders: a perspective on novel therapeutics 90
Phosphate binders for the treatment of chronic kidney disease: role of iron oxyhydroxide 88
Totale 15.638
Salva come PNG Salva come JPEG
Categoria #
all - tutte 55.737
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 55.737
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022799 0 83 21 48 46 8 50 32 7 171 102 231
2022/20232.054 145 228 87 153 163 189 9 121 877 14 52 16
2023/2024605 37 54 27 42 51 192 18 26 5 59 11 83
2024/20252.555 47 18 50 156 69 106 101 477 603 205 280 443
2025/20268.840 522 531 752 635 775 1.637 972 1.117 1.060 370 218 251
2026/2027695 304 391 0 0 0 0 0 0 0 0 0 0
Totale 17.006